EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of Citrus aurantium on Non‐Small‐Cell Lung Cancer: A Research Based on Network and Experimental Pharmacology

Liangliang Yao iD, Xuan Zhang, Chaoming Huang, Yi Cai iD, Chunpeng Craig Wan iD

BioMed Research International · 2023

DOI: 10.1155/2023/6407588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2023. Verfasst von Liangliang Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Citrus, Lung Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Research Foundation of Guangdong Province, Traditional Chinese Medicine Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To screen the main active components of Citrus aurantium through a network pharmacology approach, construct a component‐disease target network, explore its molecular mechanism for the treatment of non‐small‐cell lung cancer (NSCLC), and validate it experimentally.

Methods

The active ingredients in Citrus aurantium and the targets of Citrus aurantium and NSCLC were collected through the Traditional Chinese Medicine Systematic Pharmacology Database and Analysis Platform (TCMSP), GeneCards, and OMIM databases. The protein interaction network was constructed using the STRING database, and the component‐disease relationship network graph was analyzed using Cytoscape 3.9.1. The Metascape database can be used for GO and KEGG enrichment analyses. The Kaplan‐Meier plotter was applied for overall survival analysis of key targets of Citrus aurantium in the treatment of NSCLC. Real‐time PCR (RT‐PCR) and Western blotting were used to determine the mRNA and protein levels of key targets of Citrus aurantium for the treatment of NSCLC.

Results

Five active ingredients of Citrus aurantium were screened, and 54 potential targets for the treatment of NSCLC were found, of which the key ingredient was nobiletin and the key targets are TP53, CXCL8, ESR1, PPAR‐ α , and MMP9. GO and KEGG enrichment analyses indicated that the mechanism of nobiletin in treating NSCLC may be related to the regulation of cancer signaling pathway, phosphatidylinositol‐3 kinase (PI3K)/protein kinase B (Akt) signaling pathway, lipid and atherosclerosis signaling pathway, and neurodegenerative signaling pathway. The experimental results showed that nobiletin could inhibit the proliferation of NSCLC cells and upregulate the levels of P53 and PPAR‐ α and suppress the expression of MMP9 ( P < 0.05).

Conclusion

Citrus aurantium can participate in the treatment of NSCLC through multiple targets and pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCitrusLung NeoplasmsDrugs, Chinese HerbalMatrix Metalloproteinase 9Peroxisome Proliferator-Activated ReceptorsMedicine, Chinese TraditionalMolecular Docking Simulation

Substanzen

Matrix Metalloproteinase 9Peroxisome Proliferator-Activated ReceptorsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China.
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliat…
  • College of Agronomy, Jiangxi Agricultural University, Jiangxi Key Laboratory for Post-Harvest Technology and Nondestructive Testing of Fruits & Vegetables, Nanchang 330045, China.

ORCID-Profile: Liangliang Yao, Yi Cai, Chunpeng Craig Wan

Förderung

  • Medical Science and Technology Research Foundation of Guangdong Province
  • Traditional Chinese Medicine Research Project

Zitieren

APA

Yao, L., Zhang, X., Huang, C., Cai, Y., & Wan, C. C. (2023). The Effect of Citrus aurantium on Non‐Small‐Cell Lung Cancer: A Research Based on Network and Experimental Pharmacology. BioMed Research International. https://doi.org/10.1155/2023/6407588

Vancouver

Yao L, Zhang X, Huang C, Cai Y, Wan CC. The Effect of Citrus aurantium on Non‐Small‐Cell Lung Cancer: A Research Based on Network and Experimental Pharmacology. BioMed Research International. 2023. doi:10.1155/2023/6407588

BibTeX
@article{Yao2023,
  author = {Yao, Liangliang and Zhang, Xuan and Huang, Chaoming and Cai, Yi and Wan, Chunpeng Craig},
  title = {The Effect of Citrus aurantium on Non‐Small‐Cell Lung Cancer: A Research Based on Network and Experimental Pharmacology},
  journal = {BioMed Research International},
  year = {2023},
  doi = {10.1155/2023/6407588}
}
Kostenlos starten →